Kiniksa Pharmaceuticals International, plc Cash And Cash Equivalents At Carrying Value

Quick Answer

Kiniksa Pharmaceuticals International, plc reported Cash And Cash Equivalents At Carrying Value of $165.60 million for the year ending 2025.

  • Kiniksa Pharmaceuticals International, plc showed a decrease of -9.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Kiniksa Pharmaceuticals International, plc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Kiniksa Pharmaceuticals International, plc's Cash And Cash Equivalents At Carrying Value has grown by 263.5%.
  • Historical annual values: Fiscal year 2025: $165.60 million | Fiscal year 2024: $183.58 million | Fiscal year 2023: $107.95 million | Fiscal year 2022: $122.72 million | Fiscal year 2021: $122.47 million | Fiscal year 2020: $114.04 million | Fiscal year 2019: $46.93 million | Fiscal year 2018: $71.98 million | Fiscal year 2017: $45.56 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: